Hennion & Walsh Asset Management’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Sell
45,408
-46,946
-51% -$1.48M 0.05% 434
2026
Q1
$2.59M Sell
92,354
-4,379
-5% -$144K 0.09% 294
2025
Q4
$3.62M Buy
96,733
+10,259
+12% +$337K 0.12% 207
2025
Q3
$2.38M Sell
86,474
-1,583
-2% -$54.5K 0.09% 302
2025
Q2
$2.78M Buy
88,057
+2,186
+3% +$70.3K 0.11% 243
2025
Q1
$2.85M Buy
85,871
+10,799
+14% +$387K 0.13% 205
2024
Q4
$2.58M Buy
75,072
+20,798
+38% +$715K 0.12% 221
2024
Q3
$2.17M Buy
54,274
+9,329
+21% +$328K 0.1% 258
2024
Q2
$1.36M Buy
44,945
+30,638
+214% +$921K 0.07% 353
2024
Q1
$480K Sell
14,307
-2,458
-15% -$78.9K 0.03% 577
2023
Q4
$542K Sell
16,765
-28,130
-63% -$785K 0.03% 536
2023
Q3
$1.47M Sell
44,895
-4,732
-10% -$164K 0.09% 266
2023
Q2
$1.75M Buy
49,627
+516
+1% +$17.8K 0.1% 238
2023
Q1
$1.6M Buy
49,111
+1,165
+2% +$53.1K 0.1% 249
2022
Q4
$2.64M Buy
47,946
+12,090
+34% +$665K 0.16% 164
2022
Q3
$1.59M Buy
35,856
+1,562
+5% +$76.2K 0.1% 230
2022
Q2
$1.67M Buy
34,294
+4,575
+15% +$206K 0.1% 229
2022
Q1
$1.45M Buy
29,719
+12,151
+69% +$496K 0.08% 272
2021
Q4
$749K Buy
+17,568
New +$700K 0.04% 441

Other funds holding HRMY

Hennion & Walsh Asset Management's HRMY Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Harmony Biosciences (HRMY) stake by 51% in Q2 2026, selling an estimated $1.48M and leaving 45,408 shares worth $1.65M. The position accounts for 0.05% of the portfolio, ranked #434.

Hennion & Walsh Asset Management first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.62M in Q4 2025. 51 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Hennion & Walsh Asset Management held 45,408 shares of Harmony Biosciences worth $1.65M as of Q2 2026.
  • Hennion & Walsh Asset Management sold 46,946 Harmony Biosciences shares in Q2 2026, an estimated $1.48M.
  • Harmony Biosciences made up 0.05% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #434 holding.
  • Hennion & Walsh Asset Management first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Hennion & Walsh Asset Management's Harmony Biosciences position peaked at $3.62M in Q4 2025.
  • 51 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.